Cathrin Brisken
Impact in
- Oncology top 0.1%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 54
- Cancer Cells and Metastasis 40
- Cytokine Signaling Pathways and Interactions 7
- Cancer Risks and Factors 7
- HER2/EGFR in Cancer Research 6
-
- Breast Cancer Treatment Studies 9
- Co-authors
- Robert A. WeinbergAyyakkannu AyyananSendurai A. ManiAlicia Y. ZhouMary W. BrooksKornélia PolyákMichail ShipitsinJing Yang
- Journals
- Proceedings of the National Academy of Sciences (6 papers)Nature Communications (5 papers)Journal of Mammary Gland Biology and Neoplasia (5 papers)Breast Cancer Research (4 papers)Cancer Research (3 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Cathrin Brisken
78 papers receiving 13.8k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Oncology 8.7k
- Cancer Research 4.0k
- Molecular Biology 7.8k
- Genetics 2.3k
- Cell Biology 1.2k
Countries citing papers authored by Cathrin Brisken
This map shows the geographic impact of Cathrin Brisken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathrin Brisken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathrin Brisken more than expected).
Fields of papers citing papers by Cathrin Brisken
This network shows the impact of papers produced by Cathrin Brisken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathrin Brisken. The network helps show where Cathrin Brisken may publish in the future.
Co-authors
The 25 scholars most cited alongside Cathrin Brisken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 58 | |
| 5 | 2022 | 28 | |
| 6 | 2021 | 22 | |
| 7 | 2021 | 30 | |
| 8 | 2021 | 3 | |
| 9 | 2020 | 17 | |
| 10 | 2020 | 42 | |
| 11 | 2018 | 27 | |
| 12 | 2015 | 86 | |
| 13 | miR-148b is a major coordinator in a relapse-associated miR signature in breast tumors | 2011 | 2 |
| 14 | 2010 | 239 | |
| 15 | 2010 | 77 | |
| 16 | 2008 | 92 | |
| 17 | 2008 | 36 | |
| 18 | 2007 | 251 | |
| 19 | 2006 | 243 | |
| 20 | 2002 | 147 |
About Cathrin Brisken
Cathrin Brisken is a scholar working on Oncology, Cancer Research, Genetics, Immunology and Allergy and Molecular Biology, having authored 80 papers that have together received 14.0k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (40 papers), Estrogen and related hormone effects (22 papers), Breast Cancer Treatment Studies (9 papers), Wnt/β-catenin signaling in development and cancer (9 papers), Growth Hormone and Insulin-like Growth Factors (8 papers), Cytokine Signaling Pathways and Interactions (7 papers), Cancer Risks and Factors (7 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Oncology (8.7k citations), Cancer Research (4.0k citations), Molecular Biology (7.8k citations), Genetics (2.3k citations) and Cell Biology (1.2k citations). Cathrin Brisken has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Robert A. Weinberg, Ayyakkannu Ayyanan, Sendurai A. Mani, Alicia Y. Zhou, Mary W. Brooks, Kornélia Polyák, Michail Shipitsin, Jing Yang, Elinor Ng Eaton and Wenjun Guo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications, Journal of Mammary Gland Biology and Neoplasia, Breast Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.